Should You Buy Johnson & Johnson For Its COVID Vaccine?

Should You Buy Johnson & Johnson For Its COVID Vaccine?
Adria Cimino, The Motley Fool
·5 min read

For example, Moderna (NASDAQ: MRNA) stock climbed more than 400% last year as investors bet on its investigational vaccine. At the same time, Pfizer (NYSE: PFE) fell less than 1% last year -- even though the company led the vaccine race along with Moderna. In fact, Pfizer's vaccine eventually became the first to win Emergency Use Authorization (EUA).